celgene, page-14

From memory American Pharmaceutical partners got their shares as a result of originally being partnered with ACL to manufacture Fonda, They pulled out which is why we went to Reddys.
They kept the shares, as did Abraxis and eventually went to California Capital
Would be better if he had brought them, maybe he did with some but certainly looking back to 2004 there were issues to them

Interestingly......
"Soon-Shiong’s latest move returns him to his roots in medicine. NantOmics, funded primarily by Soon-Shiong’s California Capital Equity fund, seeks to develop medicines called kinase inhibitors that target multiple proteins to combat cancer in combination with Abraxane and other drugs."

ACL has now ventured into this space as well with their FAK inhibitors.